Amneal Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| UBS GROUP AG | 11/14/2024 | 21.77 M | $181.15 M | -0.35% | 7.03% |
| VANGUARD GROUP INC | 11/13/2024 | 14.62 M | $121.67 M | 4.50% | 4.72% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 12.41 M | $103.26 M | 100.00% | 4.01% |
| TPG GP A, LLC | 11/14/2024 | 12.33 M | $102.58 B | 0.00% | 3.98% |
| RUBRIC CAPITAL MANAGEMENT LP | 11/13/2024 | 10.72 M | $89.21 M | 0.00% | 3.46% |
| CITADEL ADVISORS LLC | 11/14/2024 | 8.89 M | $73.98 M | -10.98% | 2.87% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 4.71 M | $39.21 M | 10.02% | 1.52% |
| NEUBERGER BERMAN GROUP LLC | 11/14/2024 | 3.79 M | $31.49 M | 6.15% | 1.22% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 3.79 M | $31.51 M | 11.09% | 1.22% |
| STATE STREET CORP | 11/14/2024 | 3.51 M | $29.24 M | 3.77% | 1.14% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 2.92 M | $24.30 M | 15.38% | 0.94% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 11/14/2024 | 2.67 M | $22.21 M | 0.00% | 0.86% |
| BLACKBARN CAPITAL PARTNERS LP | 11/14/2024 | 2.41 M | $20.06 B | 20.58% | 0.78% |
| INVESCO LTD. | 11/12/2024 | 2.30 M | $19.11 M | 94.95% | 0.74% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 11/14/2024 | 2.07 M | $17.21 M | 158.84% | 0.67% |
| FOSUN INTERNATIONAL LTD | 11/14/2024 | 1.72 M | $14.32 M | -63.04% | 0.56% |
| WOODLINE PARTNERS LP | 11/14/2024 | 1.60 M | $13.35 M | 22.02% | 0.52% |
| AMERIPRISE FINANCIAL INC | 11/14/2024 | 1.59 M | $13.22 M | 14,711.34% | 0.51% |
| HENNESSY ADVISORS INC | 10/16/2024 | 1.56 M | $13.01 M | 12.63% | 0.51% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 1.40 M | $11.69 M | 16.88% | 0.45% |
| JPMORGAN CHASE & CO | 12/26/2024 | 1.30 M | $10.79 M | 149.67% | 0.42% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 1.25 M | $10.41 M | 95.31% | 0.40% |
| MORGAN STANLEY | 11/14/2024 | 1.25 M | $10.36 M | 20.24% | 0.40% |
| ASSENAGON ASSET MANAGEMENT S.A. | 10/23/2024 | 1.20 M | $10.03 M | 114.06% | 0.39% |
| ACADIAN ASSET MANAGEMENT LLC | 11/12/2024 | 1.17 M | $9.74 M | 44.25% | 0.38% |
| PHOCAS FINANCIAL CORP. | 11/07/2024 | 1.02 M | $8.45 M | -5.89% | 0.33% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 853,799 | $7.10 M | -38.15% | 0.28% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 817,584 | $6.80 M | -12.14% | 0.26% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 755,600 | $6.29 M | 10.68% | 0.24% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 624,732 | $5.20 M | -16.86% | 0.20% |
| FIRST TRUST ADVISORS LP | 11/13/2024 | 612,802 | $5.10 M | -2.61% | 0.20% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/08/2024 | 548,975 | $4.57 M | -1.64% | 0.18% |
| SEGALL BRYANT & HAMILL, LLC | 11/08/2024 | 489,162 | $4.07 M | 1.59% | 0.16% |
| ALGERT GLOBAL LLC | 11/12/2024 | 448,206 | $3.73 M | -1.00% | 0.14% |
| POLAR ASSET MANAGEMENT PARTNERS INC. | 11/14/2024 | 393,000 | $3.27 M | 122.54% | 0.13% |
| CANADA PENSION PLAN INVESTMENT BOARD | 11/14/2024 | 357,000 | $2.97 M | 11,800.00% | 0.12% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2024 | 303,253 | $2.52 M | -30.30% | 0.10% |
| SEI INVESTMENTS CO | 11/12/2024 | 296,718 | $2.47 M | 133.45% | 0.10% |
| BARCLAYS PLC | 11/19/2024 | 296,384 | $2.47 M | 134.06% | 0.10% |
| SWISS NATIONAL BANK | 11/07/2024 | 242,100 | $2.01 M | 0.00% | 0.08% |
| TREXQUANT INVESTMENT LP | 11/12/2024 | 239,562 | $1.99 M | 302.91% | 0.08% |
| RHUMBLINE ADVISERS | 11/12/2024 | 224,389 | $1.87 M | -3.79% | 0.07% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 11/01/2024 | 210,000 | $1.75 M | 42.86% | 0.07% |
| JACKSON CREEK INVESTMENT ADVISORS LLC | 11/04/2024 | 208,206 | $1.73 M | 28.71% | 0.07% |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 11/12/2024 | 203,789 | $1.76 M | -0.56% | 0.07% |
| FMR LLC | 11/13/2024 | 203,510 | $1.69 M | 25.91% | 0.07% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 195,319 | $1.63 M | -2.50% | 0.06% |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 11/12/2024 | 190,662 | $1.59 M | -2.36% | 0.06% |
| STIFEL FINANCIAL CORP | 11/14/2024 | 188,102 | $1.57 M | -0.20% | 0.06% |
| WELLS FARGO & COMPANY/MN | 11/13/2024 | 177,835 | $1.48 M | 199.66% | 0.06% |
Amneal Pharmaceuticals, Inc.institutional Ownership - FAQ's
During the previous two years, 224 institutional investors and hedge funds held shares of Amneal Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Rise Advisors, LLC: 0
UBS Group AG: 21.77 M
VANGUARD GROUP INC: 14.62 M
BlackRock Funding, Inc. /DE: 12.41 M
TPG GP A, LLC: 12.33 M
Rubric Capital Management LP: 10.72 M
45.70% of Amneal Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 169.06 M shares in the last 24 months. This purchase volume represents approximately $1.33 B in transactions.